Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
PRT-2607) HCl is a novel
17)18)13(21)11-6-3-7-23-11/h2-8
3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide
3389/fphar
ZZW-115 (5 mg/kg for 30 days
TAE-1 ethylbenzenesulfonate PRT-2607) HCl is a novelIC50: 0. 3 0. 02 M for AChE; 3. 9 0. 2 M for BuChE TAE 1 is an inhibitor of amyloid fibril formation and aggregation. Alzheimers disease (AD), a progressive neurodegenerative disorder, is characterized by the cerebral accumulation of insoluble aggregates of amyloid peptides (A). Although the precise mechanisms governing neuronal loss remains ambiguous, toxicity resulting from A activated pathways is evident. In vitro: In a previous study, the authors
US$ 5718.96
US$ 522.50
US$ 4907.70
US$ 1389.47
US$ 4772.77
US$ 3441.90
US$ 8137.50
US$ 6247.50
US$ 9602.25
US$ 7105.88
US$ 8132.25